abstract |
The present invention relates to the use of hydrocodone (morphinan-6-one, 4,5-dihydroquinolin-4-one) for the formation of novel prodrugs / compositions of hydrocodone, including benzoates and heteroarylcarboxylic acids with reduced potential for abuse of hydrocodone, alpha-epoxy-3-methoxy-17-methyl). The present invention also relates to a method of treating a patient, a pharmaceutical kit, and a method for synthesizing a conjugate of the present invention. |